BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1283499)

  • 1. Computed tomographic evaluation of bone metastases in prostatic cancer patients.
    Yoshida K; Akimoto M
    Adv Exp Med Biol; 1992; 324():197-204. PubMed ID: 1283499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
    Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar bone mineral density in prostate cancer patients with bone metastases.
    Chang CH; Tsai CS; Jim YF; Wu HC; Lin CC; Kao A
    Endocr Res; 2003 May; 29(2):177-82. PubMed ID: 12856804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of changes in bone scans of patients with osseous metastases of prostatic carcinoma.
    Prout GR; Griffin PP; Castronovo FP
    Adv Exp Med Biol; 1992; 324():233-43. PubMed ID: 1492620
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostatic bone metastases associated with multifocal Paget's disease.
    Sopov V; Groshar D
    Clin Nucl Med; 1999 Dec; 24(12):981-2. PubMed ID: 10595484
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of prostatic carcinoma with osteolytic bone metastases].
    Fukuoka H; Ishibashi Y; Masuda M; Gotoh A; Murai T; Kitamura H
    Hinyokika Kiyo; 1988 Oct; 34(10):1805-9. PubMed ID: 3245528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treated invasive cervical carcinoma. Utility of computed tomography in distinguishing between skeletal metastases and radiation necrosis.
    Yousem DM; Magid D; Scott WW; Fishman EK
    Clin Imaging; 1989 Jun; 13(2):147-53. PubMed ID: 2766078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray.
    Shimazaki J; Higa T; Akimoto S; Masai M; Isaka S
    Adv Exp Med Biol; 1992; 324():269-75. PubMed ID: 1283501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of prostate cancer associated with osteolytic bone metastases].
    Migita T; Maeda K; Ogata N
    Hinyokika Kiyo; 1999 May; 45(5):371-4. PubMed ID: 10410324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients.
    Tokuda O; Harada Y; Ohishi Y; Matsunaga N; Edenbrandt L
    Ann Nucl Med; 2014 May; 28(4):329-39. PubMed ID: 24573796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INTERLUDE: pseudo-metastases on whole body bone scan.
    Ward EV; O'Brien J; Doody O; Torreggiani WC
    JBR-BTR; 2008; 91(4):171. PubMed ID: 18817094
    [No Abstract]   [Full Text] [Related]  

  • 14. CT-guided biopsy of sacral metastatic carcinoma not visible on CT scan.
    Coombs RJ; Denman LH; Ebraheim NA; Conover SR
    Spine (Phila Pa 1976); 1988 May; 13(5):588-9. PubMed ID: 3187704
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of imaging techniques for bone metastases].
    Kratochwil C
    Urologe A; 2007 Aug; 46(8):891-6. PubMed ID: 17653687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
    BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.
    Skrinskas T; Clemons M; Freedman O; Weller I; Whyne CM
    Clin Exp Metastasis; 2009; 26(2):97-103. PubMed ID: 18941910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging diagnosis of non-lymph node metastasis of bladder carcinoma].
    Altieri V; Setola P; Ottaviano N; Ucciero G; Scognamiglio G; Montanaro V; Giannella R; Rega A; Lotti T
    Arch Ital Urol Androl; 1994 Dec; 66(5):223-8. PubMed ID: 7812300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.